All In Biotech

Drug Trial Radar · NCT07632898

Open-Label Study of IKT-001 in Pulmonary Arterial Hypertension (PAH)

Open-Label, Long-Term Extension Study to Evaluate the Safety and Tolerability of IKT-001 in Pulmonary Arterial Hypertension

Last checked: Nov 20, 2026Latest source record: Jun 8, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruitingPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Not yet recruiting

Enrollment

484

Planned (sponsor's estimate)

Start

Oct 23, 2026

Primary completion

Jun 30, 2030

Study completion Dec 30, 2030

Sponsor

Lead sponsor
Inhibikase TherapeuticsIndustry
Sponsor type
Industry
First posted
Jun 8, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a multicenter, open-label extension (OLE), single-arm study designed to assess the long-term safety and tolerability of oral IKT-001 administered once daily.

Conditions

  • Pulmonary Arterial Hypertension (PAH)

Interventions

  • IKT-001Drug

    IKT-001 tablets for PO administration

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of Treatment-emergent adverse events (TEAEs), serious TEAEs, and TEAEs of special interestTime frame: From baseline to end of study (up to 2 years or availability of commercial product)

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.